about
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reu...
Read More
3.59
0.05
(1.41%)
4,664
XNAS Volume
XNAS 24 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
NLS Pharmaceutics Ltd Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..